The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Headline
A joint advisory released April 23 from U.S. and international cybersecurity agencies, including the Cybersecurity and Infrastructure Security Agency, FBI,…
Headline
FBI Co-deputy Director Andrew Bailey discussed a rise in cyber and physical threats impacting health care. He discussed health care as the top critical…
Headline
Health care and public health was the top sector targeted for cyberthreats in 2025, according to the FBI’s latest annual report on internet crimes. There were…
Headline
The Cybersecurity and Infrastructure Security Agency released an alert March 27 on a vulnerability in F5 BIG-IP Access Policy Manager software that is being…
Headline
The Food and Drug Administration has issued an early alert for certain Streamline Airless System Hemodialysis Bloodlines and B3 Low Volume Bloodlines by B.…
Headline
The FBI released an alert March 20 warning of a technique used by cyber actors working on behalf of the Iranian government to conduct malicious cyber activity…